NCT01736683 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 35
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 74
- units
- Participants
- groups
- description
- Sotatercept 0.1 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to either the 0.1 mg/kg arm or the 0.3 mg/kg arm. Efficacy and safety data were assessed by a Steering Committee. Based upon the occurrence of dose-limiting toxicity (DLT) in ≤ 1/5 subjects in Cycle 1 in the 0.1 mg/kg and 0.3 mg/kg treatment groups, the 0.5 mg/kg treatment group began inclusion in the randomization scheme.
- id
- BG000
- title
- Sotatercept 0.1 mg/kg
- description
- Sotatercept 0.3 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to either the 0.1 mg/kg arm or the 0.3 mg/kg arm. Efficacy and safety data were assessed by a Steering Committee. Based upon the occurrence of dose-limiting toxicity (DLT) in ≤ 1/5 subjects in Cycle 1 in the 0.1 mg/kg and 0.3 mg/kg treatment groups, the 0.5 mg/kg treatment group began inclusion in the randomization scheme.
- id
- BG001
- title
- Sotatercept 0.3 mg/kg
- description
- Sotatercept 0.5 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to one of the active treatment arms. Efficacy and safety data were assessed by a Steering Committee. Based upon the occurrence of dose-limiting toxicity (DLT) in ≤ 1/6 subjects in Cycle 1 in the 0.5 mg/kg treatment group, the 1.0 mg/kg treatment group began inclusion in the randomization scheme.
- id
- BG002
- title
- Sotatercept 0.5 mg/kg
- description
- Sotatercept 1.0 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to one of the active treatment arms. Efficacy and safety data were assessed by a Steering Committee. Based upon the occurrence of dose-limiting toxicity (DLT) in ≤ 1/6 subjects in Cycle 1 in the 1.0 mg/kg treatment group, the 2.0 mg/kg treatment group began inclusion in the randomization scheme. Following evaluation of all treatment group data by the Steering Committee, enrollment continued only in the 1.0 mg/kg arm because the arm had the greatest frequency of erythroid hematological improvement (HI-E).
- id
- BG003
- title
- Sotatercept 1.0 mg/kg
- description
- Sotatercept 2.0 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to one of the active treatment arms. Efficacy and safety data were assessed by a Steering Committee. The 2.0 mg/kg sotatercept dose was reduced to 1.5 mg/kg for ongoing and newly enrolled participants by protocol amendment.
- id
- BG004
- title
- Sotatercept 2.0 mg/kg
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.3
- value
- 67
- group Id
- BG001
- spread
- 6.9
- value
- 75
- group Id
- BG002
- spread
- 8.0
- value
- 69
- group Id
- BG003
- spread
- 8.2
- value
- 71
- group Id
- BG004
- spread
- 13.0
- value
- 69
- group Id
- BG005
- spread
- 8.4
- value
- 70
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 17
- title
- <65 years
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 32
- title
- >=65 - <75 years
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 25
- title
- >=75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 28
- title
- Female
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 18
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 46
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 19
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 49
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 23
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 18
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 48
- title
- White
- measurements
- comment
- not asked on CRF
- group Id
- BG000
- value
- NA
- comment
- not asked on CRF
- group Id
- BG001
- value
- NA
- comment
- not asked on CRF
- group Id
- BG002
- value
- NA
- comment
- not asked on CRF
- group Id
- BG003
- value
- NA
- comment
- not asked on CRF
- group Id
- BG004
- value
- NA
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG005
- value
- NA
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 24
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 15
- group Id
- BG003
- value
- 18
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 50
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 24
- title
- France
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.110
- value
- 1.70
- group Id
- BG001
- spread
- 0.054
- value
- 1.75
- group Id
- BG002
- spread
- 0.093
- value
- 1.70
- group Id
- BG003
- spread
- 0.089
- value
- 1.68
- group Id
- BG004
- spread
- 0.043
- value
- 1.56
- group Id
- BG005
- spread
- 0.095
- value
- 1.68
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- meters
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 21.79
- value
- 85.3
- group Id
- BG001
- spread
- 13.90
- value
- 79.5
- group Id
- BG002
- spread
- 13.97
- value
- 77.9
- group Id
- BG003
- spread
- 15.55
- value
- 73.5
- group Id
- BG004
- spread
- 7.25
- value
- 56.4
- group Id
- BG005
- spread
- 16.14
- value
- 75.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 29
- title
- <=200 mIU/mL
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 15
- title
- >200 to <=500 mIU/mL
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 25
- title
- >500 mIU/mL
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 5
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Erythropoietin level
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 12
- title
- < 4 units (Low Transfusion Burden)
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 18
- group Id
- BG003
- value
- 27
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 62
- title
- >= 4 units (High Transfusion Burden)
- description
- RBC units transfused during 56 days prior to the start of treatment.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Red Blood Cell (RBC) Transfusion Burden Categories
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- title
- 0 ESA therapies
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 23
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 45
- title
- 1 ESA therapy
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 24
- title
- 2 ESA therapies
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- title
- 3 ESA therapies
- description
- Myelodysplastic Syndromes (MDS)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Number of Previous Erythropoiesis-Stimulating Agents (ESA) Therapies for Myelodysplastic Syndromes
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 11
- title
- 0 non-ESA agents
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 25
- title
- 1 non-ESA agent
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 17
- title
- 2 non-ESA agents
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 8
- title
- 3 non-ESA agents
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 6
- title
- 4 non-ESA agents
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- title
- 5 non-ESA agents
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 5
- title
- >5 non-ESA agents
- description
- Erythropoiesis-Stimulating Agents (ESA)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Number of Previous Non-ESA Agents for Myelodysplastic Syndromes (MDS)
- unit Of Measure
- Participants
- population Description
- All randomized participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 35
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 74
- units
- Participants
- groups
- description
- Sotatercept 0.1 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to either the 0.1 mg/kg arm or the 0.3 mg/kg arm. Efficacy and safety data were assessed by a Steering Committee. Based upon the occurrence of dose-limiting toxicity (DLT) in ≤ 1/5 subjects in Cycle 1 in the 0.1 mg/kg and 0.3 mg/kg treatment groups, the 0.5 mg/kg treatment group began inclusion in the randomization scheme.
- id
- BG000
- title
- Sotatercept 0.1 mg/kg
- description
- Sotatercept 0.3 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to either the 0.1 mg/kg arm or the 0.3 mg/kg arm. Efficacy and safety data were assessed by a Steering Committee. Based upon the occurrence of dose-limiting toxicity (DLT) in ≤ 1/5 subjects in Cycle 1 in the 0.1 mg/kg and 0.3 mg/kg treatment groups, the 0.5 mg/kg treatment group began inclusion in the randomization scheme.
- id
- BG001
- title
- Sotatercept 0.3 mg/kg
- description
- Sotatercept 0.5 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to one of the active treatment arms. Efficacy and safety data were assessed by a Steering Committee. Based upon the occurrence of dose-limiting toxicity (DLT) in ≤ 1/6 subjects in Cycle 1 in the 0.5 mg/kg treatment group, the 1.0 mg/kg treatment group began inclusion in the randomization scheme.
- id
- BG002
- title
- Sotatercept 0.5 mg/kg
- description
- Sotatercept 1.0 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to one of the active treatment arms. Efficacy and safety data were assessed by a Steering Committee. Based upon the occurrence of dose-limiting toxicity (DLT) in ≤ 1/6 subjects in Cycle 1 in the 1.0 mg/kg treatment group, the 2.0 mg/kg treatment group began inclusion in the randomization scheme. Following evaluation of all treatment group data by the Steering Committee, enrollment continued only in the 1.0 mg/kg arm because the arm had the greatest frequency of erythroid hematological improvement (HI-E).
- id
- BG003
- title
- Sotatercept 1.0 mg/kg
- description
- Sotatercept 2.0 mg/kg administered via subcutaneous injection every third week (Q3W). Participants were randomized to one of the active treatment arms. Efficacy and safety data were assessed by a Steering Committee. The 2.0 mg/kg sotatercept dose was reduced to 1.5 mg/kg for ongoing and newly enrolled participants by protocol amendment.
- id
- BG004
- title
- Sotatercept 2.0 mg/kg
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.3
- value
- 67
- group Id
- BG001
- spread
- 6.9
- value
- 75
- group Id
- BG002
- spread
- 8.0
- value
- 69
- group Id
- BG003
- spread
- 8.2
- value
- 71
- group Id
- BG004
- spread
- 13.0
- value
- 69
- group Id
- BG005
- spread
- 8.4
- value
- 70
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 17
- title
- <65 years
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 32
- title
- >=65 - <75 years
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 25
- title
- >=75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 28
- title
- Female
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 18
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 46
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 19
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 49
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 23
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 18
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 48
- title
- White
- measurements
- comment
- not asked on CRF
- group Id
- BG000
- value
- NA
- comment
- not asked on CRF
- group Id
- BG001
- value
- NA
- comment
- not asked on CRF
- group Id
- BG002
- value
- NA
- comment
- not asked on CRF
- group Id
- BG003
- value
- NA
- comment
- not asked on CRF
- group Id
- BG004
- value
- NA
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG005
- value
- NA
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 24
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 15
- group Id
- BG003
- value
- 18
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 50
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 24
- title
- France
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.110
- value
- 1.70
- group Id
- BG001
- spread
- 0.054
- value
- 1.75
- group Id
- BG002
- spread
- 0.093
- value
- 1.70
- group Id
- BG003
- spread
- 0.089
- value
- 1.68
- group Id
- BG004
- spread
- 0.043
- value
- 1.56
- group Id
- BG005
- spread
- 0.095
- value
- 1.68
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- meters
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 21.79
- value
- 85.3
- group Id
- BG001
- spread
- 13.90
- value
- 79.5
- group Id
- BG002
- spread
- 13.97
- value
- 77.9
- group Id
- BG003
- spread
- 15.55
- value
- 73.5
- group Id
- BG004
- spread
- 7.25
- value
- 56.4
- group Id
- BG005
- spread
- 16.14
- value
- 75.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 29
- title
- <=200 mIU/mL
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 15
- title
- >200 to <=500 mIU/mL
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 25
- title
- >500 mIU/mL
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 5
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Erythropoietin level
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 12
- title
- < 4 units (Low Transfusion Burden)
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 18
- group Id
- BG003
- value
- 27
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 62
- title
- >= 4 units (High Transfusion Burden)
- description
- RBC units transfused during 56 days prior to the start of treatment.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Red Blood Cell (RBC) Transfusion Burden Categories
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- title
- 0 ESA therapies
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 23
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 45
- title
- 1 ESA therapy
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 24
- title
- 2 ESA therapies
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- title
- 3 ESA therapies
- description
- Myelodysplastic Syndromes (MDS)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Number of Previous Erythropoiesis-Stimulating Agents (ESA) Therapies for Myelodysplastic Syndromes
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 11
- title
- 0 non-ESA agents
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 25
- title
- 1 non-ESA agent
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 17
- title
- 2 non-ESA agents
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 8
- title
- 3 non-ESA agents
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 6
- title
- 4 non-ESA agents
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- title
- 5 non-ESA agents
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 5
- title
- >5 non-ESA agents
- description
- Erythropoiesis-Stimulating Agents (ESA)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Number of Previous Non-ESA Agents for Myelodysplastic Syndromes (MDS)
- unit Of Measure
- Participants
- population Description
- All randomized participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle